(MENAFN Press) Dubai-United Arab Emirates - Wednesday, November 14th 2012
Elsevier “ the world-leading provider of scientific, technical and medical information products and services “ announced the scientific program of its highly anticipated 2nd Middle East Vaccine Congress, which will be held from 14th-15th December, 2012, at the Rotana Beach Hotel & Resort in Abu Dhabi, UAE. Organized in partnership with global communications and event management company MCI, the two-day event is expected to secure wide-spread regional participation, bringing together vaccine experts from the healthcare industry, academia and government.
Set to tackle key issues related to vaccine research, manufacturing, policy, safety and regulation, the 2nd Middle East Vaccine Congress's plenary sessions will delve into topics that encompass vaccine safety, breakthroughs as well as future challenges. Speakers will include senior vaccine professionals, researchers and policy-makers from Germany, Italy, the UK, the UAE, KSA, Kuwait, Oman, Lebanon, Jordan and Egypt.
Amongst the event's featured keynotes are: Ms. Houda Langar,Regional Adviser of the Essential Vaccines and Biologicals Policy (VAC Unit) at the World Health Organization - Egypt; Ms. Farida Al Hosani, Manager of the Communicable Diseases Department at the Health Authority Abu Dhabi (HAAD); Mr. Ziad Memish,Deputy Minister for Public Health and a Professor at the College of Medicine at KSA's Alfaisal University; Mr. Fred Zepp,Medical Director & Chairman of the Department of Pediatrics at Germany's Johannes Gutenberg University; Mr. Muhieddine Seoud, Vice Chairman ofand a Professor atthe Department of Obstetrics and Gynecology at the American University of Beirut (AUB); and Mr. Ray Spier, Emeritus Professor of Science and Engineering Ethics atthe UK's University of Surrey, among others.
"We're very excited about this year's lineup of keynotes and panelists, all of who come from rich medical and academic backgrounds and will offer invaluable insights into the latest issues, developments and challenges facing the regional vaccine industry today," said Haifa Al Mughrabi, Regional Director of Elsevier ME. "As professional congress organizers, we at Elsevier aim to create enabling platforms that allow for constructive dialogue and industry progress in order to enhance the quality and effectiveness of healthcare in the MENA. We are confident that the 2nd Middle East Vaccine Congress will serve as such a platform, and we encourage relevant professionals in the region to register while the opportunity is still available."
In addition to learning from experts, opinion leaders and exhibiting organizations, Congress attendees will have access to unique, high-quality content and industry updates; meet with a range of exhibitors presenting cutting-edge products and services; and learn about the development of vaccines for infectious diseases.
Online registration will remain open until 6th December, with onsite registration available on the first day of the Congress. To register online, please visit www.vaccinecongress.ae.
